Coronavirus Vaccine

Trump's attorney general drops fraud case tied to COVID vaccinations

Health Secretary Robert F. Kennedy Jr., who for decades has sown doubt about the safety of vaccines contrary to evidence and research by scientists.

US Attorney-General Pam Bondi arrives to speak during the visit of US President Donald Trump to the Department of Justice to address its workers, in Washington, March 14, 2025.
 A COVID-19 TESTING center in France in 2022.

Israeli breakthrough: Freeze-dried COVID vaccine needs no refrigeration

 A woman is seen preparing a dose of the COVID vaccine.

Israel kicks off new COVID vaccine campaign targeting JN1 variant: What you need to know

US President Joe Biden participates in a bilateral meeting with Israeli Prime Minister Benjamin Netanyahu on the sidelines of the 78th U.N. General Assembly in New York City, US, September 20, 2023.

Biden tests positive for COVID-19


European Medicines Agency recommends Novavax add warning to their COVID-19 vaccine

The European Medicines Agency (EMA) is recommending that Novavax should start putting a warning label on their COVID-19 vaccines due to a small number of reported cases of heart inflammation.

 The COVID-19 vaccine (illustrative).

Pfizer profit beats estimates on higher demand for COVID products

Revenue from the antiviral pill, Paxlovid, exceeded market estimates by more than $1b, while vaccine sales surged 20%, helping the drugmaker reaffirm the combined 2022 revenue forecast of $54b.

 People pose with syringe with needle in front of displayed Pfizer logo in this illustration taken.

COVID vaccine recipients report changes in menstrual bleeding - study

42% of the nearly 40,000 respondents reported heavier bleeding than usual during their menstrual cycles in the first three months after being vaccinated.

 Prepping the vaccine at a Health Ministry center in Jerusalem's Malcha Mall

COVID-19 booster shots are crucial, according to a Yale study

New study by Yale, UNC, shows that peak antibody levels achieved by getting vaccinated with an mRNA vaccine exceed those gained from natural infection.

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

Researchers create COVID-19 antibodies from eggs - study

Researchers say that birds are ideal for producing antibodies quickly and cheaply, and these could potentially be used to treat or help prevent COVID-19.

An employee of an organic supermarket poses for the photographer with an egg from an organic farm in Berlin, February 25, 2013.

Moderna: New booster protects better against variants

Moderna said it is simultaneously developing an additional vaccine adapted to Omicron and based on BA.4/5, in accordance with the latest FDA guidelines

 A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021.

Americans no longer see COVID-19 as a public health threat - poll

For the first time since a March 2020 Pew Research Center poll, most Americans don't see the coronavirus as a threat to public health.

 People wear masks around Times Square, as cases of the infectious coronavirus Delta variant continue to rise in New York City, New York, US, July 23, 2021

Feiglin: Those under 30 need to avoid COVID-19 vaccine 'like fire'

The former MK called vaccinating little kids a "heinous act" • The Health Ministry: "Nonsense said by someone with no understanding or knowledge on the topic"

 Moshe Feiglin attends a Health Committee meeting at the Knesset, the Israeli parliament in Jerusalem, on November 16, 2021.

COVID-19 hero: Pfizer CEO Albert Bourla reflects on the past, future

Bourla revealed that he would donate the $1 million award to building a Holocaust museum in his hometown in an interview for The Jerusalem Post.

 DR. ALBERT BOURLA on the King David Hotel’s rooftop overlooking Jerusalem, on June 28, ahead of the Genesis Prize ceremony.

Pfizer CEO Albert Bourla receives honorary doctorate from Technion

Bourla was recognized for his exceptional leadership in developing the first safe and effective COVID-19 vaccine, which remains the gold standard for vaccines against the novel coronavirus.

 Pfizer CEO Dr. Albert Bourla at the ceremony